Literature DB >> 17432711

Increase in glutamate as a sensitive indicator of extracellular matrix integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance spectroscopy study.

Teruo Kimura1, Masaki Ohkubo, Hironaka Igarashi, Ingrid L Kwee, Tsutomu Nakada.   

Abstract

OBJECT: The authors of previous studies based on diffusion tensor imaging have indicated that there are two types of peritumoral edema-namely, edema with preserved structural integrity of the glial matrix and edema with compromised glial matrix. The authors of this study hypothesized that functionality of the glutamate (Glu)-glutamine shuttle, a vital neuron-glia interaction, may be differentially affected by peritumoral edema. They tested this hypothesis using proton magnetic resonance (MR) spectroscopy on a 3.0-tesla system that is capable of quantifying Glu without need of editing.
METHODS: Twenty-three patients, each with a single brain tumor mass and peritumoral edema (nine high-grade gliomas, eight metastatic brain tumors, and six meningiomas), and nine healthy individuals participated in this study. Single-voxel proton MR imaging targeting the region of peritumoral edema was performed using a 3.0-tesla system. Glutamate levels in the peritumoral edema of nonglial tumors was significantly elevated (p < 0.01) compared with edema associated with glial tumors or normal white matter. The finding confirmed that peritumoral edema in nonglial tumors is distinct from that of glial tumors, as previously indicated in diffusion tensor imaging studies. The authors hypothesized that the former condition represents a compensatory increase in activities of the Glu-glutamine shuttle brought about by simple expansion of the extracellular space due to edema.
CONCLUSIONS: The assessment of Glu concentrations in peritumoral edema using 3.0-tesla proton MR spectroscopy may be developed into an objective index of the structural integrity of the glial matrix.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17432711     DOI: 10.3171/jns.2007.106.4.609

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  A combined diffusion tensor imaging and Ki-67 labeling index study for evaluating the extent of tumor infiltration using the F98 rat glioma model.

Authors:  Kai Wang; Tingting Ha; Xuzhu Chen; Shaowu Li; Lin Ai; Jun Ma; Jianping Dai
Journal:  J Neurooncol       Date:  2018-01-02       Impact factor: 4.130

2.  Maturational decrease of glutamate in the human cerebral cortex from childhood to young adulthood: a 1H-MR spectroscopy study.

Authors:  Mami Shimizu; Yuji Suzuki; Kenichi Yamada; Satoshi Ueki; Masaki Watanabe; Hironaka Igarashi; Tsutomu Nakada
Journal:  Pediatr Res       Date:  2017-07-12       Impact factor: 3.756

3.  Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.

Authors:  Andreana P Haley; Mitzi M Gonzales; Takashi Tarumi; Steven C Miles; Katayoon Goudarzi; Hirofumi Tanaka
Journal:  Metab Brain Dis       Date:  2010-11-10       Impact factor: 3.584

Review 4.  VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.

Authors:  Elizabeth R Gerstner; Dan G Duda; Emmanuelle di Tomaso; Peter A Ryg; Jay S Loeffler; A Gregory Sorensen; Percy Ivy; Rakesh K Jain; Tracy T Batchelor
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

5.  Hints on new applications of emission tomography and magnetic resonance in neuro-oncology.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08       Impact factor: 10.057

6.  Glioma infiltration of the corpus callosum: early signs detected by DTI.

Authors:  K Kallenberg; T Goldmann; J Menke; H Strik; H C Bock; F Stockhammer; J H Buhk; J Frahm; P Dechent; M Knauth
Journal:  J Neurooncol       Date:  2013-01-24       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.